# TROGARZO

NDC: 62064-122
Generic name: ibalizumab
Labeler / Manufacturer: Theratechnologies Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180420

FDA application: BLA761065

## Active ingredients

- IBALIZUMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62064-122"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62064-122
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c548ad82-9d1f-4d16-95b6-4e6106badf43